Tankred Schewe

Title: Innovations and Contributions of Tankred Schewe

Introduction

Tankred Schewe is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing drug bioavailability. With a total of 3 patents to his name, Schewe's work focuses on developing innovative compounds with valuable pharmacological properties.

Latest Patents

One of Schewe's latest patents is centered on the composition and methods for providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (HMLO). This patent highlights the improvement of absorption of HMLO by incorporating bile acids, such as desoxycholic acid or dehydrocholic acid, into pharmaceutical preparations. Another significant patent involves the development of new 1-(2-hydroxyaryl)-alkane-1-on-oximes, detailing their preparation and applicability in pharmaceutical formulations. These compounds are characterized by their anti-asthmatic, anti-anaphylactic, antiphlogistic, antihypertensive, spasmolytic, antirheumatic, and antithrombotic potentials, making them valuable in treating various medical conditions.

Career Highlights

Throughout his career, Tankred Schewe has worked with esteemed institutions, including Humboldt University of Berlin and VEB Arzneimittelwerk Dresden. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Tankred Schewe has collaborated with notable colleagues, including Jurgen Slapke and Hartmut Kuehn. These partnerships have likely enhanced his research efforts and led to innovative advancements in the pharmaceutical field.

Conclusion

Tankred Schewe's contributions to pharmaceutical innovations demonstrate his commitment to improving drug efficacy and patient outcomes. His patents reflect a deep understanding of pharmacology and a dedication to advancing medical science.